Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.56 USD | +2.02% | +9.49% | -28.88% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.88% | 146M | |
+42.45% | 50.93B | |
-0.35% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.99% | 26.02B | |
-21.85% | 18.9B | |
+7.59% | 13.21B | |
+24.32% | 12.17B | |
+29.99% | 12.16B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Transcript : Syros Pharmaceuticals, Inc., Q2 2023 Earnings Call, Aug 08, 2023